by Sara Lidman, Karolinska Institutet SARS-CoV-2 infection inhibited SGs formation independent of eIF2α. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-54996-3 Researchers at Karolinska Institutet have discovered how the SARS-CoV-2 virus, which causes COVID-19, manipulates human proteins to replicate and evade the immune system. The results have been published in Nature Communications. The new study shows that SARS-CoV-2 uses human proteins called G3BP...
Tag: <span>SARS – CoV2</span>
Post
Curcumin spray shows promise in fighting SARS-CoV-2 and flu viruses
By Dr. Sanchari Sinha Dutta, Ph.D.Jan 24 2024A team of scientists from Thailand has developed a curcumin-containing oro-nasal film spray, which shows potential antiviral activity and mucosal immunity-boosting activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza viruses. The study is published in the Virology Journal. Study: A novel film spray containing curcumin...
Post
SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year
Neha MathurBy Neha MathurOct 30 2023Reviewed by Susha Cheriyedath, M.Sc. Image Credit: Created with the assistance of DALL·E 3 In a recent study posted to the medRxiv preprint* server, researchers pursued evidence of whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens, of which spike (S) protein is highly immunogenic, persist beyond the acute phase...